Home » Stock Quotes » SHE:300009

Anhui Anke Biotechnology (Group) Co Ltd SHE:300009

Today's live share price, quote history, chart & news

Price:
13.79 CNY
Change:
+0.01 (0.07%)
Price open 13.81
Previous close 13.78
Market cap 14.48B
Volume 7.67M
Day high 14.04
Day low 13.68
Year high 18.88
Year low 13.20

About Anhui Anke Biotechnology (Group) Co Ltd

Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.

Overview
Name Anhui Anke Biotechnology (Group) Co Ltd
Exchange Shenzhen Stock Exchange
Sector Healthcare
Industry Biotechnology
Country China

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.